To access this element change to forms mode OFF
Grant Award View - GA201498
Targeting skeletal muscle for the treatment of insulin resistance
GA ID:
GA201498
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,470,120.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Targeting skeletal muscle for the treatment of insulin resistance
Purpose:
Insulin resistance is a condition that leads to high-blood glucose and poor muscle function. It is the fastest growing chronic disease in Australia and the major contributor to type-2 diabetes and sarcopenia. We urgently need new treatment strategies. We have identified a series of novel therapeutic targets for the treatment of insulin resistance. This project will analyse these therapeutic targets in preclinical models and improve our understanding of the molecular events of insulin resistance.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009642
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA